by sfrazee | Jul 19, 2024
By Tomas J. Philipson July 19, 2024 As President Biden works to shore up support before the election and after a difficult first debate his administration is hastening to finalize a major proposal designed to address high drug prices. Unfortunately, the...
by sfrazee | Apr 26, 2024
By Tomas J. Philipson April 26, 2024 Both the Left and the Right need a better understanding of how product improvements through novel innovation work. For decades, progressives have fought to weaken America’s world-leading protections for property rights....
by sfrazee | Apr 12, 2024
By Tomas J. Philipson April 12, 2024 In their April 9 op-ed, “Big Pharma’s high prices don’t drive innovation,” Avik Roy and Gregg Girvan argued that Medicare’s new authority to demand lower prices from drug manufacturers will not result in the development and...